PT100946A - PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN AND ITS PREPARATION PROCESS - Google Patents
PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN AND ITS PREPARATION PROCESSInfo
- Publication number
- PT100946A PT100946A PT100946A PT10094692A PT100946A PT 100946 A PT100946 A PT 100946A PT 100946 A PT100946 A PT 100946A PT 10094692 A PT10094692 A PT 10094692A PT 100946 A PT100946 A PT 100946A
- Authority
- PT
- Portugal
- Prior art keywords
- calcitonin
- pharmaceutical compositions
- preparation process
- compositions containing
- preparation
- Prior art date
Links
- 102000055006 Calcitonin Human genes 0.000 title 1
- 108060001064 Calcitonin Proteins 0.000 title 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 title 1
- 229960004015 calcitonin Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI912703A IT1251685B (en) | 1991-10-11 | 1991-10-11 | PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT100946A true PT100946A (en) | 1993-10-29 |
Family
ID=11360856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT100946A PT100946A (en) | 1991-10-11 | 1992-10-09 | PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN AND ITS PREPARATION PROCESS |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0607229A1 (en) |
| JP (1) | JPH07500099A (en) |
| AU (1) | AU2683492A (en) |
| BR (1) | BR9206707A (en) |
| CA (1) | CA2120755A1 (en) |
| IT (1) | IT1251685B (en) |
| MX (1) | MX9205852A (en) |
| PT (1) | PT100946A (en) |
| WO (1) | WO1993006854A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2285921A (en) * | 1994-01-31 | 1995-08-02 | Leilani Lea | Sublingual administration of medicaments |
| DE726075T1 (en) * | 1995-02-08 | 1996-12-12 | Therapicon Srl | Non-inorganic pharmaceutical saline solutions for endonasal administration |
| WO1997021448A1 (en) * | 1995-12-13 | 1997-06-19 | Dullatur Limited | A calcitonin preparation |
| IT1294191B1 (en) * | 1997-09-05 | 1999-03-22 | Alfa Wassermann Spa | Composition for treating osteoporosis, Paget's disease or hypercalcemia, comprises calcitonin dissolved in acidic sodium chloride solution |
| GB2368792A (en) * | 2000-10-06 | 2002-05-15 | Roger Randal Charles New | Absorption enhancers |
| ITRM20010048A1 (en) * | 2001-01-30 | 2002-07-30 | Gregorio Mauro De | METHOD FOR PREPARING PHYSIOLOGICALLY ACCEPTABLE AQUEOUS SOLUTIONS SO OBTAINED. |
| GB0308732D0 (en) * | 2003-04-15 | 2003-05-21 | Axcess Ltd | Absorption enhancers |
| GB0308734D0 (en) | 2003-04-15 | 2003-05-21 | Axcess Ltd | Uptake of macromolecules |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60188315A (en) * | 1984-03-07 | 1985-09-25 | Yamanouchi Pharmaceut Co Ltd | Antipruritic plaster containing glycyrretic acid |
| JPS61267528A (en) * | 1984-11-26 | 1986-11-27 | Yamanouchi Pharmaceut Co Ltd | Transnasal calcitonin agent containing absorbefacient |
| EP0327756B1 (en) * | 1987-11-13 | 1994-01-26 | Smithkline Beecham Farmaceutici S.p.A. | Pharmaceutical compositions comprising a calcitonin and a glycyrrhizinate as absorption enhancer |
| JPH078806B2 (en) * | 1990-08-16 | 1995-02-01 | 旭化成工業株式会社 | Nasal emulsion containing calcitonin |
-
1991
- 1991-10-11 IT ITMI912703A patent/IT1251685B/en active IP Right Grant
-
1992
- 1992-10-08 EP EP92920956A patent/EP0607229A1/en not_active Withdrawn
- 1992-10-08 AU AU26834/92A patent/AU2683492A/en not_active Abandoned
- 1992-10-08 WO PCT/EP1992/002321 patent/WO1993006854A1/en not_active Application Discontinuation
- 1992-10-08 BR BR9206707A patent/BR9206707A/en not_active Application Discontinuation
- 1992-10-08 JP JP5506629A patent/JPH07500099A/en active Pending
- 1992-10-08 CA CA002120755A patent/CA2120755A1/en not_active Abandoned
- 1992-10-09 MX MX9205852A patent/MX9205852A/en unknown
- 1992-10-09 PT PT100946A patent/PT100946A/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9206707A (en) | 1995-10-31 |
| ITMI912703A0 (en) | 1991-10-11 |
| IT1251685B (en) | 1995-05-19 |
| CA2120755A1 (en) | 1993-04-15 |
| EP0607229A1 (en) | 1994-07-27 |
| JPH07500099A (en) | 1995-01-05 |
| ITMI912703A1 (en) | 1993-04-11 |
| WO1993006854A1 (en) | 1993-04-15 |
| MX9205852A (en) | 1993-06-01 |
| AU2683492A (en) | 1993-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ITMI922400A0 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN | |
| BR9404114A (en) | Pharmaceutical composition and its preparation process | |
| IL95351A0 (en) | 17beta-acyl-4-aza-5alpha-androst-1-en-3-ones and pharmaceutical compositions containing them | |
| IL90067A0 (en) | 1alpha-hydroxyvitamin-d compounds and pharmaceutical compositions containing them | |
| HU9802116D0 (en) | 19-nor-d-vitamin compounds with biologically effect and pharmaceutical compositions containing them | |
| NZ244766A (en) | Bi-aromatic compounds and pharmaceutical compositions | |
| EE03108B1 (en) | Pharmaceutical composition | |
| FI981777A0 (en) | Pharmaceutical composition | |
| NZ235109A (en) | Aminoacetamide derivatives and pharmaceutical compositions thereof | |
| IL112001A0 (en) | Compounds containing basic and acidic termini and pharmaceutical compositions containing them | |
| IL99658A0 (en) | Substituted azetidinones and pharmaceutical compositions containing them | |
| IL99725A0 (en) | Saturated hydroxyalkylquinoline acids and pharmaceutical compositions containing them | |
| BR9200058A (en) | PHARMACEUTICAL COMPOUND AND COMPOSITION | |
| IL93727A0 (en) | Pharmaceutical compositions containing polyoxometallate and certain such compounds | |
| MX9200622A (en) | PHARMACEUTICAL COMPOSITION | |
| NZ233011A (en) | Thieno-triazole-diazepine and pharmaceutical compositions | |
| PT100946A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING A CALCITONIN AND ITS PREPARATION PROCESS | |
| IL90065A0 (en) | 1alpha-hydroxyvitamin-d homologs and pharmaceutical compositions containing them | |
| KR900012897A (en) | Guanidine derivatives and pharmaceutical compositions containing them | |
| IL109712A0 (en) | Arylating agents and pharmaceutical compositions containing them | |
| IL103747A0 (en) | Saccharin derivatives and pharmaceutical compositions containing them | |
| IL89155A0 (en) | Ouabain-like compounds and pharmaceutical compositions containing them | |
| EE9400337A (en) | Pharmaceutical compositions containing interferon alpha and their uses | |
| IL106214A0 (en) | Thf-ypsilon2 analogs and pharmaceutical compositions comprising them | |
| IL99011A0 (en) | 2-(9-fluorenonyl)-carbapenems and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB1A | Laying open of patent application |
Effective date: 19930526 |
|
| FC3A | Refusal |
Effective date: 19990503 |